Delivery Order SPE2DB22D2007-SPE2DB25FJ3VR
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,898.80 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with a completion date of September 3, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.98 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a dermatological pharmaceutical product. The contract, issued on September 12, 2025, with ultimate completion by September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency for ZORYVE 0.3% Foam in a 60-gram unit, with a ceiling value of $1,291.47. The contract is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and was awarded on a competitive basis with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $4,330.47. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides ZORYVE 0.3% Foam in 60-gram quantities with a ceiling value of $1,179.18. The contract represents a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $1,846.66 to supply Zoryve 0.3% Foam in 60-gram quantities. The contract was competitively awarded without set-aside designation and carries a completion date of September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.57 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM on August 27, 2025, with completion scheduled for August 28, 2025. This competitive award, issued under a firm fixed-price contract with no set-aside designation, represents a single delivery order for a topical pharmaceutical product. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...